Related Experiment Videos
Characterization of CELO virus proteins that modulate the pRb/E2F pathway
1Research Institute of Molecular Pathology, 1030 Vienna, Austria.
Journal of Virology
|July 10, 1999
Summary
Avian adenovirus CELO transforms cells by activating E2F-dependent gene expression. Two CELO proteins, GAM-1 and Orf22, interact with the retinoblastoma protein (pRb) to achieve this, revealing novel mechanisms for cell transformation.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Avian adenovirus CELO shares cell transformation capabilities with human adenoviruses.
- CELO virus lacks sequence homology with human adenovirus transforming regions.
- Understanding CELO's mechanism for activating E2F-dependent gene expression is crucial for cell cycle control research.
Purpose of the Study:
- To identify CELO virus factors responsible for activating E2F-dependent gene expression.
- To investigate the interaction of CELO viral proteins with the retinoblastoma protein (pRb).
- To elucidate the novel mechanisms by which CELO virus proteins mediate cell transformation.
Main Methods:
- Utilized an E2F-inducible reporter system to screen for CELO virus open reading frames.
- Employed co-immunoprecipitation assays to study protein-protein interactions between CELO proteins and pRb.
- Analyzed protein motifs involved in pRb binding and their role in E2F activation.
Main Results:
- Identified two CELO virus open reading frames, GAM-1 and Orf22, that cooperate to activate E2F-inducible reporter systems.
- Both GAM-1 and Orf22 proteins interact with the retinoblastoma protein (pRb).
- Orf22 binds to the pRb pocket domain via a novel motif distinct from the E1A LxCxD, while GAM-1 interacts with pRb outside this domain.
Conclusions:
- CELO virus utilizes GAM-1 and Orf22 proteins to activate E2F-dependent gene expression, contributing to cell transformation.
- Orf22's novel pRb-binding motif represents a new class of viral oncoprotein interaction.
- These findings expand our understanding of viral oncogenesis and pRb pathway modulation.